Deal facts
- Buyer
- ROQUETTE
- Target
- IFF PHARMA SOLUTIONS BUSINESS
- Deal value
- Not disclosed
- Announced
- 13 January 2025
- Status
- In review
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- Not stated
Sources
ROQUETTE has agreed to acquire the IFF Pharma Solutions business in a strategic acquisition. The transaction was announced on 13 January 2025 and currently remains subject to regulatory approval. The deal involves entities operating within the chemical and pharmaceutical sectors, specifically covering codes NaceSectorsC_20_1_6, NaceSectorsC_21, and NaceSectorsC_20_5_9. No financial consideration or deal value has been disclosed to the public at this stage.
The target operates as a distinct business unit within the broader pharmaceutical supply chain. ROQUETTE intends to integrate these assets to expand its capabilities in the sector. The acquisition is currently in the review phase, pending necessary regulatory clearances before completion. Further details regarding the specific scope of operations or the final timeline for closing have not been reported. The transaction represents a significant step for the buyer in its current strategic direction.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CMA invitation to comment
ROQUETTE to acquire IFF PHARMA SOLUTIONS BUSINESS
ROQUETTE to acquire IFF PHARMA SOLUTIONS BUSINESS
EU DG COMP
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
GSK plc to acquire Nuvalent, Inc
GSK plc has agreed to acquire Nuvalent, Inc in a strategic acquisition valued at $10.6 billion. The transaction, announced and completed on 15 July 2026, involves full c…
- Buyer
- GSK plc
- Target
- Nuvalent, Inc
- Deal value
- USD 10,600,000,000
- Deal type
- strategic acquisition
Volex plc to acquire Kepler SignalTek Ltd
Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on…
- Buyer
- Volex plc
- Target
- Kepler SignalTek Ltd
- Deal value
- USD 89,400,000
- Deal type
- strategic acquisition
Lixte Biotechnology Holdings, Inc. to acquire Nomad Transportable Power Systems, Inc.
Lixte Biotechnology Holdings, Inc. has agreed to acquire Nomad Transportable Power Systems, Inc. in a strategic acquisition within the Healthcare sector. The transaction…
- Buyer
- Lixte Biotechnology Holdings, Inc.
- Target
- Nomad Transportable Power Systems, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Public Company Management Corporation to acquire Physicians Capital Management Corporation
Public Company Management Corporation has agreed to acquire Physicians Capital Management Corporation in a strategic acquisition within the healthcare sector. The transa…
- Buyer
- Public Company Management Corporation
- Target
- Physicians Capital Management Corporation
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
ROQUETTE
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive